Clinical trial
Immunotherapy Combined With Yttrium-90 RadioEmbolization in the Treatment of Colorectal Cancer With Liver Metastases [iRE-C - Clinical Trial]
NCT04108481 is registered in ClinicalTrials.gov with University of Iowa as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Immunotherapy Combined With Yttrium-90 RadioEmbolization in the Treatment of Colorectal Cancer With Liver Metastases [iRE-C - Clinical Trial]
- Lead sponsor
- University of Iowa
- Phase
- Phase 1
- Overall status
- Terminated
- Start date
- October 5, 2020
- Completion date
- November 17, 2023
- Enrollment
- 5 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
colo-rectal cancer, colon cancer, colorectal adenocarcinoma, colorectal cancer metastatic, colorectal carcinoma, colorectal neoplasms, liver metastases, liver metastasis colon cancer, metastatic colorectal cancer, rectal cancer